About the journal
Diabetes Technology & Therapeutics is a journal published by Mary Ann Liebert, Inc. in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Mary Ann Liebert, Inc.
- ISSN
- 1520-9156 · 1557-8593
- Country
- United States
- Access
- Not open access / not declared
- Official website
- https://www.liebertpub.com/loi/dia
Index listings
- MEDLINE · 1999-01-01
- Indexing
- MEDLINE
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3904
Last recorded publication year
2026
h-index
130
i10-index
2225
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 89%
- ORCID iDs in current deposits
- 69%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Diabetes technology and therapeutics
- Source type
- journal
- NLM unique ID (PubMed)
- 100889084
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Diabetes Management and Research
- Diabetes Management and Research
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Diabetes and associated disorders
- Diabetes and associated disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Show all subjects (50)
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Diabetes Management and Education
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Mobile Health and mHealth Applications
- Mobile Health and mHealth Applications
- Spectroscopy Techniques in Biomedical and Chemical Research
- Spectroscopy Techniques in Biomedical and Chemical Research
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- Gestational Diabetes Research and Management
- Gestational Diabetes Research and Management
- Diet and metabolism studies
- Diet and metabolism studies
- Electrochemical sensors and biosensors
- Electrochemical sensors and biosensors
- Intravenous Infusion Technology and Safety
- Intravenous Infusion Technology and Safety
- Inhalation and Respiratory Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
- Heart Rate Variability and Autonomic Control
- Heart Rate Variability and Autonomic Control
- Diabetic Foot Ulcer Assessment and Management
- Diabetic Foot Ulcer Assessment and Management
- Bariatric Surgery and Outcomes
- Bariatric Surgery and Outcomes
- Adipokines, Inflammation, and Metabolic Diseases
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Adipokines, Inflammation, and Metabolic Diseases
- Retinal Diseases and Treatments
- Retinal Diseases and Treatments
- Advanced Glycation End Products research
- Advanced Glycation End Products research
- Natural Antidiabetic Agents Studies
- Natural Antidiabetic Agents Studies
- Pharmacology and Obesity Treatment
- Pharmacology and Obesity Treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ